342 related articles for article (PubMed ID: 17109250)
1. [Differentiated treatment of diabetics with an acute coronary syndrome].
Hamm CW; Hamann A
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
[No Abstract] [Full Text] [Related]
2. [Risk stratification in the acute coronary syndrome. Diabetes--a diagnostic dilemma].
Giannitsis E; Katus HA
Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S211-4. PubMed ID: 17109251
[No Abstract] [Full Text] [Related]
3. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
Wiersma JJ; Trip MD; Piek JJ
Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
[TBL] [Abstract][Full Text] [Related]
4. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
5. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
[No Abstract] [Full Text] [Related]
6. [Therapeutic strategies to improve the outcome of patients with diabetes mellitus and acute coronary syndrome].
Cavallini C
G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):13S-20S. PubMed ID: 16749287
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of unstable coronary disease].
Préda I
Orv Hetil; 2002 Apr; 143(15):757-65. PubMed ID: 11979994
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Leesar MA
Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
[No Abstract] [Full Text] [Related]
9. Use of low molecular weight heparins and glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease.
Mosenkis A; Berns JS
Semin Dial; 2004; 17(5):411-5. PubMed ID: 15461751
[TBL] [Abstract][Full Text] [Related]
10. The year in non-ST-segment elevation acute coronary syndromes.
Giugliano RP; Braunwald E
J Am Coll Cardiol; 2005 Sep; 46(5):906-19. PubMed ID: 16139143
[No Abstract] [Full Text] [Related]
11. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
12. [The BARI 2D study].
Mafrici A; Briguori C
G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
[No Abstract] [Full Text] [Related]
13. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
Ferguson JJ; Wilson JM; Diez J
Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
[TBL] [Abstract][Full Text] [Related]
14. Unstable angina.
Natarajan M
Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
[No Abstract] [Full Text] [Related]
15. Prevention of cardiovascular events in diabetes.
Malcolm J; Meggison H; Sigal R
Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
[No Abstract] [Full Text] [Related]
16. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes.
Cavendish JJ; Fugit RV; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1839-43. PubMed ID: 15537484
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of thrombolysis in acute myocardial infarction.
Gambhir DS
Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
[No Abstract] [Full Text] [Related]
18. LDL-Cholesterol is the King.
Goumas GS
Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
[No Abstract] [Full Text] [Related]
19. Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction.
Lincoff AM
J Invasive Cardiol; 2002 Feb; 14 Suppl A():1A-2A. PubMed ID: 11847401
[No Abstract] [Full Text] [Related]
20. [Coronary artery disease in diabetic patients].
Henry P
Rev Prat; 2008 Sep; 58(14):1561-4. PubMed ID: 18839684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
